FDA OKs Nico.Lab's AI stroke software

By AuntMinnie.com staff writers

November 30, 2020 -- The U.S. Food and Drug Administration (FDA) cleared Dutch medtech company Nico.Lab's StrokeViewer LVO, an artificial intelligence (AI) algorithm that detects image characteristics associated with a large vessel occlusion (LVO).

The cloud-based software sends a notification to the medical specialists involved with the stroke case minutes after a patient arrives in the hospital. Physicians are able to use their smartphones both in the hospital and at home to inspect the CT images in a web viewer and diagnose a stroke.

This is the firm's first FDA clearance, but StrokeViewer is currently in use in Australia and Europe.

Copyright © 2020 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking